Tiare 90mg Tablet
Marketer
MSN Laboratories
Salt Composition
Ticagrelor (90mg)
Overview Tiare 90mg Tablet
CardioGuard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiovascular disease. CardioGuard 90mg is also indicated for individuals recovering from a heart attack, experiencing severe angina, or post-stent placement. Its use helps prevent recurrent heart attacks, strokes, and clot formation within stents. Concurrent use with aspirin, another antiplatelet medication, is usually prescribed by your physician. CardioGuard 90mg can be administered with or without food, consistently at the same time daily; continued use is crucial even during symptom remission. Discontinuing treatment elevates the risk of future cardiac events. The most frequent adverse effect is bleeding, potentially prolonged after injury. While typically mild and self-resolving, persistent bleeding requires medical attention. Some individuals may experience mild shortness of breath, usually subsiding with ongoing treatment; worsening or persistent dyspnea warrants consultation. CardioGuard 90mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Pre-existing conditions should be disclosed to your doctor before commencing treatment.
Uses of Tiare 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Tiare 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 90mg Tiare tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
Common Side effects of Tiare 90mg Tablet:
- Bleeding
- Breathlessness
How to use Tiare 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 90mg Tiare tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent daily timing is recommended.
How Tiare 90mg Tablet works:
Ninety-milligram Tiare tablets are antiplatelet agents. Their mechanism involves inhibiting platelet aggregation, thus reducing the risk of dangerous thrombus formation. This action consequently minimizes the likelihood of cardiovascular events such as myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Tiare 90mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Tiare 90mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Tiare 90mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Tiare 90mg Tablets.
KidneySAFE IF PRESCRIBED
Tiare 90mg tablets can be administered to patients with kidney impairment without dosage modification. Data regarding the use of Tiare 90mg tablets in individuals undergoing renal dialysis is currently scarce.
LiverCAUTION
Patients with liver impairment should use Tiare 90mg tablets cautiously, potentially requiring dosage modification under medical supervision. Tiare 90mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Tiare 90mg Tablet :
Should you forget a Tiare 90mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tiare 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |





